Navigation Links
Now hear this: Stanford researchers identify forerunners of inner-ear cells that enable hearing
Date:2/26/2013

STANFORD, Calif. Researchers at the Stanford University School of Medicine have identified a group of progenitor cells in the inner ear that can become the sensory hair cells and adjacent supporting cells that enable hearing. Studying these progenitor cells could someday lead to discoveries that help millions of Americans suffering from hearing loss due to damaged or impaired sensory hair cells.

"It's well known that, in mammals, these specialized sensory cells don't regenerate after damage," said Alan Cheng, MD, assistant professor of otolaryngology. (In contrast, birds and fish are much better equipped: They can regain their sensory cells after trauma caused by noise or certain drugs.) "Identifying the progenitor cells, and the cues that trigger them to become sensory cells, will allow us to better understand not just how the inner ear develops, but also how to devise new ways to treat hearing loss and deafness."

The research will be published online Feb. 26 in Development. Cheng is the senior author. Former medical student Taha Jan, MD, and postdoctoral scholar Renjie Chai, PhD, share lead authorship of the study. Roel Nusse, PhD, a professor of developmental biology, is a co-senior author of the research.

The inner ear is a highly specialized structure for gathering and transmitting vibrations in the air. The auditory compartment, called the cochlea, is a snail-shaped cavity that houses specialized cells with hair-like projections that sense vibration, much like seaweed waving in the ocean current. These hair cells are responsible for both hearing and balance, and are surrounded by supporting cells that are also critical for hearing.

Twenty percent of all Americans, and up to 33 percent of those ages 65-74, suffer from hearing loss. Hearing aids and, in severe cases, cochlear implants can be helpful for many people, but neither address the underlying cause: the loss of hair cells in the inner ear. Cheng and his
'/>"/>

Contact: Krista Conger
kristac@stanford.edu
650-725-5371
Stanford University Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Hear This: 3-D Printing Creates Lifelike Artificial Ears
2. Immune cells engineered in lab to resist HIV infection, Stanford study shows
3. Optogenetics illuminates pathways of motivation through brain, Stanford study shows
4. Stanford/Yale study gives insight into subtle genomic differences among our own cells
5. Mechanism found for destruction of key allergy-inducing complexes, Stanford researchers say
6. Stanford bioengineer Karl Deisseroth wins NIH Transformative Research Award
7. MBL and Stanford scientists receive 2012 Lasker Award for Basic Medical Research
8. Little evidence of health benefits from organic foods, Stanford study finds
9. Mathematics or memory? Stanford study charts collision course in brain
10. Stanford/Intel study details power of new chip to diagnose disease, analyze protein interactions
11. Community health centers compare well with private practices, Stanford researcher finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2014)... 21, 2014 Originally approved by ... GSK’s Flovent (fluticasone propionate) is a synthetic ICS ... for the maintenance treatment of asthma prophylactically in ... two formulations, Diskus and HFA, which received the ... active ingredient, fluticasone propionate, can bind to glucocorticoid ...
(Date:9/21/2014)... An experienced review website in the global ... list and announced that FatCow ( http://www.top10bestseohosting.com/go/FatCow.com/ ), GoDaddy ... , There has been a boom in websites in ... an increase in the number of web hosting companies ... affordable prices. VPS (Virtual Private Server) is the method ...
(Date:9/21/2014)... OH (PRWEB) September 21, 2014 C8 ... District of Ohio as the list of 20 possible ... been narrowed down to six, reports Wright & Schulte ... chosen from the almost 2500 C8 lawsuits filed that ... or testicular cancer as a result of being exposed ...
(Date:9/20/2014)... Vegas, NV (PRWEB) September 21, 2014 ... by Dr. Kenneth Pullman that is helping thousands of ... their diabetes symptoms without shots, pills, or prescriptions has ... review. , “There are currently tens of millions ... both Type 1 and Type 2 diabetes, and unfortunately, ...
(Date:9/20/2014)... Baja, Mexico (PRWEB) September 20, 2014 ... announced the resort did not experience any damage in ... all amenities and activities available. , Hurricane Odile struck ... bringing intense wind, rain and powerful surf conditions. Located ... del Palmar Islands of Loreto experienced some heavy rain, ...
Breaking Medicine News(10 mins):Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 2Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 3Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 4Health News:Top10BestSEOHosting.com: FatCow, GoDaddy And Bluehost Are The Best VPS Hosting Suppliers 2Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 2Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 3Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 4Health News:Diabetes Protocol: Review Exposes Kenneth Pullman’s Breakthrough Discovery About Diabetes Management 2Health News:Villa del Palmar at the Islands of Loreto Fully Functioning After Hurricane 2Health News:Villa del Palmar at the Islands of Loreto Fully Functioning After Hurricane 3
... , , , ... JAZZ ) today announced financial results for the second quarter ended June ... quarter were $37.3 million, compared to $15.5 million for the quarter ended ... milestone payment from UCB Pharma Limited that was received in July 2008 ...
... , LAKEWOOD, Colo., Aug. 11 Mesa Laboratories, ... of Directors has declared a regular quarterly cash dividend of 10 ... to shareholders of record at the close of business on August ... manufactures and markets electronic instruments and disposables for industrial, pharmaceutical and ...
... VERNON HILLS, Ill., Aug. 11 Lifeline Vascular Access(SM), the ... the launch of the Lifeline Vascular Access Network(SM) - ... to deliver quality care and impact industry-wide health-care cost savings. ... money for end-stage renal disease (ESRD) patients and the entire ...
... , , , ... a worldwide manufacturer and distributor of agricultural equipment, today ... Norman L. Boyd, has been appointed by Governor Perdue ... of Community Health champions access to affordable, quality health ...
... , New Studies Show Healthy Lifestyle Habits ... WASHINGTON, Aug. 11 Though years ago everyone was looking for ... of chronic disease, scientific researchers today recognize that it is the ... a healthy diet, using dietary supplements and exercising regularly -- that ...
... who ate healthy and remained active were protected, study ... a Mediterranean diet, which emphasizes fruits, vegetables, legumes and ... the risk of developing Alzheimer,s disease, a new study ... 12 issue of the Journal of the American ...
Cached Medicine News:Health News:Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 2Health News:Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 3Health News:Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 4Health News:Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 5Health News:Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 6Health News:Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 7Health News:Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 8Health News:Lifeline Vascular Access Launches New Platform for Physicians to Share Best Practices and Improve Vascular Access Care 2Health News:AGCO Senior Executive, Norm Boyd, Receives Executive Appointment to Georgia's Board of Community Health by Georgia Governor Sonny Perdue 2Health News:Healthy Lifestyles Are 'In' - Magic Bullets Are 'Out' 2Health News:Healthy Lifestyles Are 'In' - Magic Bullets Are 'Out' 3Health News:Healthy Lifestyles Are 'In' - Magic Bullets Are 'Out' 4Health News:Mediterranean Diet Plus Exercise Lowers Alzheimer's Risk 2Health News:Mediterranean Diet Plus Exercise Lowers Alzheimer's Risk 3
(Date:9/19/2014)... , September 19, 2014 ... ) has announced the addition of the ... report to their offering.      ... have been broadly classified into wide categories ... used for the treatment of different gynecological ...
(Date:9/19/2014)... Sept. 19, 2014  For Cloud Pharmaceuticals, Inc., ... and development, partnering is an integral part of ... design new drugs and identify early stage, preclinical, ... further their development. The company also partners with ... this business model, Cloud Pharmaceuticals will be participating ...
(Date:9/19/2014)... The American Association for Homecare (AAHomecare) is ... has joined the AAHomecare Corporate Partner Program. ... have been actively involved in AAHomecare for much of ... grown into a major global manufacturer of home medical ... to increase efforts on behalf of the HME sector ...
Breaking Medicine Technology:Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 3Cloud Pharmaceuticals Announces Partnering Sessions and Presentation Schedule 2Drive Medical Design & Manufacturing Joins AAHomecare Corporate Partner Program 2
... CAMBRIDGE, Mass. , Aug. 4 ... therapies to treat autoimmune diseases and cancer by modulating ... Antonin (Tony) de Fougerolles , Ph.D., as Chief Scientific ... provide leadership for the company’s research and early-stage product ...
... , THE WOODLANDS, Texas , Aug. 3 ... LXRX ), a biopharmaceutical company focused on discovering breakthrough ... its second quarter 2010 financial results on Monday, August ... will hold a conference call to discuss its clinical development ...
Cached Medicine Technology:Tolerx Appoints Antonin de Fougerolles, Ph.D., as Chief Scientific Officer 2Tolerx Appoints Antonin de Fougerolles, Ph.D., as Chief Scientific Officer 3Tolerx Appoints Antonin de Fougerolles, Ph.D., as Chief Scientific Officer 4Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2010 Financial Results 2
... Electronic Medical Record system. It stores patient chart ... and everything you would normally put in a ... Someone has to write them, file them, find ... Paper Charts get lost. They find their way ...
... precision demands absolute knowledge. Access ... Lomb Zyoptix Diagnostic Workstation, uniting ... Wavefront Aberrometer and Orbscan IIz ... they supply critically important data. ...
ZYMAR™ ophthalmic solution is an anti-infective prescription eye drop that your doctor may instruct you to use if you have an eye infection caused by bacteria. Bacterial conjunctivitis is the e...
LUMIGAN® is a powerful eye drop medication for lowering IOP. IOP is short for intraocular pressure or eye pressure. LUMIGAN® is the first in a new class of medication....
Medicine Products: